🌍 Exciting updates from #TargetRWE at #ISPE2024! We’re thrilled to present our latest research on sequential nested trial (SNT) emulation at the International Society for Pharmacoepidemiology (ISPE) 2024 meeting in Berlin this weekend. Our study explores innovative approaches to evaluating #TreatmentEffectiveness and safety. Delve into the findings and learn more about implications for #DrugDevelopment 💡👉 https://prn.to/4fTxkDR #RealWorldEvidence #Pharmacoepidemiology #ClinicalResearch #HealthResearch #HealthcareInnovation #StudyDesign #ObservationalTrialDesign
Target RWE’s Post
More Relevant Posts
-
We're very excited about ISPE 2024! We have research on #COVID, #RealWorldData, and #CausalInference and more for you to see. Take a look and see what you might not want to miss 👉🏼 https://ow.ly/HBgt50SNx30 #ISPEAnnual2024 #Pharmacoepidemiology International Society for Pharmacoepidemiology
To view or add a comment, sign in
-
Next week at #ISPEAnnual2024, join Aetion’s Co-Founder and President Jeremy Rassen for the pre-conference skills course, “Propensity Scores in Pharmacoepidemiology,” where he and co-presenter Dr. John Seeger will explain how propensity scores can be used to mitigate confounding through standard observational approaches. #pharmacoepidemiology #icpe
To view or add a comment, sign in
-
Going to #ISPE? Stop by Joseph Zabinski, Ph.D.'s presentation on August 26 from 12-1230pm CEST to learn how OM1, Inc. capabilities can help advance your clinical work
Join Joseph Zabinski, Ph.D. at #ISPEAnnual2024 to learn about novel approaches of #AI-based methods to address data gaps in #realworlddata sources to determine fit for purpose approaches for your study. Researchers who design #RWD studies and stakeholders who evaluate the findings of RWD studies would benefit from attending. 📍 Not attending ISPE this year? Send us a message for more info on the presentation 📩: https://hubs.ly/Q02LCzmc0 International Society for Pharmacoepidemiology #AIHealth #RWE #Pharmacoepidemiology
To view or add a comment, sign in
-
#Rwtdttt package released today - the parametric Waiting Time Distribution has come to R! 🎉 After a year of hard work together with a great team (Malcolm Gillies, Sabrina Giometto and Olga Paoletti), I am so proud and delighted to share the package with all of you R users, and I hope it will allow many more to use the parametric Waiting Time Distribution for estimation of prescription lengths in #pharmacoepidemiology. You will find the package for free download and use at github here: https://lnkd.in/eSDNgnvF You will probably want to start by reading the README.md file for instructions on how to install the procedure in R. In comments to this post I will share some notes on the release and provide references if you want to know more about the method and its use. Here though I will end by sharing a picture of the proud parents of the projects at our informal online release party this morning :-)
To view or add a comment, sign in
-
Gaps in data are a common problem in #realworlddata sources. Key variables may only be found in unstructured #clinicalnotes or missing entirely from the electronic medical records (#EMR). Join Joseph Zabinski, Ph.D. at #ISPEAnnual2024 to learn about novel approaches of #AI-based methods to address data gaps in #RWD. International Society for Pharmacoepidemiology #AIHealth #RWE #Pharmacoepidemiology
To view or add a comment, sign in
-
Let's meet at #ICPE in Berlin next month! Our #RWD and scientific experts including Jeff Brown and Arnold Chan will be available to discuss how we can help you find clinical solutions for your needs. Meet with us: https://ow.ly/VUxZ30sFloU #Pharmacoepidemiology #RealWorldData #epidemiology
To view or add a comment, sign in
-
For our dear client Dr. Willmar Schwabe we conducted and published a study about real world effectiveness of Hawthorn special extract WS 1442. In the present study, we investigated antiarrhythmic effects of WS 1442 compared with magnesium/potassium in a large collective of outpatients using the IQVIA Disease Analyzer (DA) database. This study showed that in intake of hawthorn special extract WS 1442 was associated with a significantly lower #incidence of #atrial #fibrillation, #tachycardia, and other #cardiac #arrhythmias compared to #magnesium/#potassium, indicating its potential in treating and preventing such conditions. IQVIA Germany #epidemiology #phytopharmaceutical #cardiology #medical_affairs
To view or add a comment, sign in
-
GLP-1 receptor agonist drugs, originally intended for diabetes treatment, have experienced a substantial increase in usage for weight loss in recent times. However, a recent study has raised concerns about their potential risks. The study found that the use of GLP-1 RA for 1–3 years was associated with an elevated risk of all thyroid cancer (adjusted hazard ratio [HR] 1.58, 95% CI 1.27–1.95) and medullary thyroid cancer (adjusted HR 1.78, 95% CI 1.04–3.05). These findings underscore the importance of carefully considering the potential consequences of prolonged GLP-1 RA use beyond their established benefits for diabetes management. #DiabetesManagement #GLP1RA #HealthResearch #WeightLoss #ThyroidCancer #HealthcareAwareness #MedicationSafety #Endocrinology #HealthConcerns #Epidemiology #Meddata Read more about it here: https://lnkd.in/eW26nXiE
To view or add a comment, sign in
-
Pharmacoepidemiology is a peer-reviewed, open access journal on high-quality epidemiological, clinical research across the fields of clinical pharmacology and epidemiology, published quarterly online by MDPI.
🔔 Special Issue Announcement! Recent Advances in the Pharmacoepidemiology of Antirheumatic Medication Stay up to date with the current and shifting trends in the field of pharmacoepidemiology of antirheumatic medications. This Special Issue is now accepting a wide range of contributions, including original research articles, systematic and narrative review articles, commentaries, letters, and other materials that facilitate a deeper understanding of this fundamental topic. For more information and submission guidelines, please visit: https://lnkd.in/dsE-PWzv #Pharmacoepidemiology #AntirheumaticMedication
To view or add a comment, sign in
-
Explore the latest research on rescue therapy for supratherapeutic concentrations of calcineurin inhibitors using potent cytochrome P450 inducers. Rescue Therapy for Supratherapeutic Concentrations of Calcineurin Inhibitors Using Potent Cytochrome P450 Inducers Read the full article: https://lnkd.in/d_ew4hu3 #CalcineurinInhibitors #CytochromeP450 #DrugTherapy #pharmacoepidemiology
To view or add a comment, sign in
4,267 followers